{"data":{"id":"us-nv/nrs-695a.1841","jurisdiction":"us-nv","citation":"NRS 695A.1841","heading":"Limitation on cost-sharing obligation for insulin covered under benefit contract covering prescription insulin drugs.","body":"1. A society that offers or issues a benefit contract which provides coverage for prescription insulin drugs shall not impose against an insured a deductible, copayment, coinsurance or other cost-sharing obligation that is greater than $35 for a 30-day supply of a prescription insulin drug which is prescribed to the insured and covered by the society, regardless of the amount or type of prescription insulin drug prescribed.\n2. As used in this section:\n(a) “Diabetes” includes type I, type II and gestational diabetes.\n(b) “Prescription insulin drug” means a prescription drug that contains insulin and is used to control blood glucose levels for the purpose of treating diabetes.","path":["TITLE 57 — INSURANCE","CHAPTER 695A - FRATERNAL BENEFIT SOCIETIES"],"source_url":"https://www.leg.state.nv.us/NRS/NRS-695A.html#NRS695ASec1841","current_through":"2025 session (NRS as revised 2026-08-25)","vintage":"","retrieved_at":"2026-09-03T05:51:46Z","sha256":"1eb516440f60abf8ad406a1770dac35ea5495d08cb914325a1fa736e035405a0","source_id":"us-nv","stale":true,"prev":"us-nv/nrs-695a.184","next":"us-nv/nrs-695a.1843"},"notice":"GroundRules: Original legal text. Not legal advice."}